Trial intelligence / Profile preview

PK of Sirolimus, Mycophenolate Mofetil and Fluvastatin in Renal Transplant

NCT00223028Phase 4Completed

Sponsor
Universitätsklinikum Schleswig-Holstein
Start
Apr 2005
Modality
Small Molecules
01

Overview

A Phase 4 trial of sirolimus, mycophenolate mofetil, fluvastatin in kidney transplant rejection, hyperlipidemia, sponsored by Universitätsklinikum Schleswig-Holstein. Started Apr 2005; status: completed.

02

Drugs

sirolimusmycophenolate mofetilfluvastatin
03

Conditions

kidney transplant rejectionhyperlipidemia

Beyond the preview

Go deeper on NCT00223028.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00223028.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call